Skip to content
Lower risk Drug recall · FDA · Published January 8, 2024

Teva recalls Budesonide 9mg tablets: Failed dissolution specs

Teva Pharmaceuticals recalls 9mg Budesonide Extended-Release Tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact for return instructions.

🇺🇸 FDA recall #D-0275-2024DrugTeva ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA, Inc400 Interpace Pkwy Bldg A · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

Teva is recalling 9mg Budes: Budesonide Extended-Release Tablets that failed dissolution tests. This could mean the medication isn't working properly for users. Read more at govinfonow.com/recall/32888-teva-recalls-budesonide-9mg-tablets-failed-dissolution-specs.

Source Summary by GovInfoNow · govinfonow.com/recall/32888-teva-recalls-budesonide-9mg-tablets-failed-dissolution-specs · Updated August 17, 2026 · FDA enforcement record: FDA #D-0275-2024

Cite this page

“Teva recalls Budesonide 9mg tablets: Failed dissolution specs.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32888-teva-recalls-budesonide-9mg-tablets-failed-dissolution-specs. Based on FDA recall #D-0275-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0275-2024%22&limit=1).

The FDA announced on Jan. 8, 2024, that Teva Pharmaceuticals USA, Inc. voluntarily recalled Budesonide Extended-Release Tablets 9mg due to failed dissolution specifications. The recall affects 10,672 bottles distributed nationwide.

How to tell if you have it

  • Brand: Teva
  • Product: Budesonide Extended-Release Tablets 9mg, 30-count bottle
  • NDC: 0591-2510-30
  • Lot #: 100047273
  • Expiration: 07/2025

The hazard

The product failed dissolution specifications, according to the FDA. The recall is classified as Class II.

Context

GovInfoNow's records show Teva Pharmaceuticals USA, Inc. has 59 other recalls on record since April 2, 2012. Other recent recalls of similar products include Novartis Diovan 160mg Tablets (Aug. 4, 2026), AvKARE Rosuvastatin Tablets 10mg (Dec. 31, 2025) and Inventia Chlorthalidone (Sept. 3, 2026).

How to tell if you have this one

Check for the 9mg Budesonide Extended-Release Tablets, 30-count bottle, Rx Only. Look for NDC 0591-2510-30 and lot number 100047273.

  • Brand
    Teva
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Details

    Identify the product by checking the NDC code 0591-2510-30 and lot number 100047273.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 30 days after the firm started it.

1. Firm started the recall: Jan 8, 202412. FDA classified it Class II: Jan 26, 202423. Published in FDA’s Enforcement Report: Feb 7, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Teva recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0275-2024 (January 8, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0275-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA